From October 17 to 21, researchers and physicians from NYU Langone Health join colleagues from around the world at the annual meeting of the European Society for Medical Oncology in Berlin, Germany.
Below are notable sessions featuring our faculty. For a full list of presentations, visit the ESMO meeting website.
Saturday, October 18
Poster Presentation
2091eTiP – STK-012: A first-in-class alpha/beta IL-2 receptor biased partial agonist, in untreated metastatic non-small cell lung cancer (NSCLC)
NYU Langone Presenter: Salman R. Punekar, MD
Time: All day
Location: Hall 25
Monday, October 20
Proffered Paper Session
ECOG-ACRIN EA6174: STAMP: Surgically treated adjuvant merkel cell carcinoma with pembrolizumab, a phase III trial
NYU Langone Presenter: Janice Mehnert, MD
Time: 8:30–10:15 AM
Location: Cologne Auditorium – CityCube A
ePoster Presentations
1125P – Beyond checkpoint inhibitors: Real-world (rw) treatment (tx) practices and clinical outcomes in advanced/recurrent endometrial cancer (a/r EC) post-immune checkpoint inhibitor (ICI) tx
NYU Langone Author: Bhavana Pothuri, MD
236eP – Translational PK/PD modelling of LY4170156, an antibody-drug conjugate linked to exatecan via a novel cleavable polysarcosine linker
NYU Langone Author: Bhavana Pothuri, MD
1146P – Genomic landscape of HRD signature (HRDsig), CCNE1 amplified (amp) and ERBB2 altered (alt) ovarian cancers (OC)
NYU Langone Author: Bhavana Pothuri, MD
1152P – Cyclin E1 amplification (CCNE1amp) is associated with race and poor outcomes in endometrial cancer (EC)
NYU Langone Author: Bhavana Pothuri, MD
1067P – Results from the first-in-human phase I study of LY4170156, an antibody drug conjugate (ADC) targeting folate receptor alpha in recurrent platinum resistant high-grade serous ovarian cancer (HGSOC)
NYU Langone Author: Bhavana Pothuri, MD
